12-94333527-C-T
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM5BP4_Moderate
The NM_016122.3(CEP83):c.1532G>A(p.Arg511Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000273 in 1,613,342 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R511L) has been classified as Uncertain significance.
Frequency
Consequence
NM_016122.3 missense
Scores
Clinical Significance
Conservation
Publications
- nephronophthisis 18Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp, G2P
- nephronophthisis 2Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_016122.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CEP83 | NM_016122.3 | MANE Select | c.1532G>A | p.Arg511Gln | missense | Exon 13 of 17 | NP_057206.2 | ||
| CEP83 | NM_001042399.2 | c.1532G>A | p.Arg511Gln | missense | Exon 12 of 16 | NP_001035858.1 | |||
| CEP83 | NM_001346457.2 | c.1532G>A | p.Arg511Gln | missense | Exon 12 of 17 | NP_001333386.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CEP83 | ENST00000397809.10 | TSL:1 MANE Select | c.1532G>A | p.Arg511Gln | missense | Exon 13 of 17 | ENSP00000380911.4 | ||
| CEP83 | ENST00000339839.9 | TSL:1 | c.1532G>A | p.Arg511Gln | missense | Exon 12 of 16 | ENSP00000344655.5 | ||
| CEP83 | ENST00000547232.5 | TSL:1 | n.1433G>A | non_coding_transcript_exon | Exon 13 of 17 | ENSP00000447783.1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152096Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000161 AC: 4AN: 248940 AF XY: 0.0000222 show subpopulations
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1461246Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 8AN XY: 726844 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000125 AC: 19AN: 152096Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74278 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1
In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge
Nephronophthisis 18 Uncertain:1
This sequence change replaces arginine with glutamine at codon 511 of the CEP83 protein (p.Arg511Gln). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and glutamine. This variant is present in population databases (no rsID available, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with CEP83-related conditions. ClinVar contains an entry for this variant (Variation ID: 1419704). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CEP83 protein function. This variant disrupts the p.Arg511 amino acid residue in CEP83. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 24882706). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at